The Oxford University spinout secures investment from Centrica Innovations to support growth.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Development of a vaccine candidate with potential to save millions worldwide will be accelerated in commercialisation deal with Blue Water Vaccines.
The Oxford University spinout plans to use the investment to fuel its structural mass spectrometry to identify new medicines.
The University of Oxford spinout also inks clinical paper in Lancet Psychiatry, appoints CEO and sets up Oxford HQ and London development hub.
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round.